HINSDALE, Ill.--(BUSINESS WIRE)--Illinois Cancer Specialists (ICS), united in healing with The US Oncology Network, is pleased to announce the addition of medical oncologist Arti A. Lakhani, M.D., to better serve newly diagnosed cancer patients. Dr. Lakhani, a Hinsdale native, is currently available to see new patients at the ICS Hinsdale treatment center within 24 hours of diagnosis.
“Providing immediate access to care from a highly-trained medical oncologist is critical for newly diagnosed patients who are often distressed over their condition,” said Donald Sweet, M.D., F.A.C.P., hematologist and medical oncologist with the Illinois Cancer Specialists Hinsdale facility. “Newly diagnosed patients face many critical issues that are best dealt with immediately. They want guidance from a well-qualified medical oncologist who will be a long-term member of their care team. With the arrival of Dr. Lakhani, newly diagnosed patients in the Hinsdale area can be seen quickly, and they’ll get the quality care and attention they desire. Dr. Lakhani is a highly qualified, compassionate oncologist trained in the very latest treatment options who can provide immediate comfort and care to these patients during a very difficult and stressful time.”
A graduate of Rush University Medical School, Dr. Lakhani also completed her Internship and Residency at Rush, which is ranked among the top academic medical centers in the nation. She attended Loyola University Medical Center/Hines VA Medical Center, where she completed a fellowship in medical oncology and hematology. Throughout her career, Dr. Lakhani has published numerous articles in the fields of hematology and medical oncology, and she is a member of the American Society of Clinical Oncology and the American Society of Hematology. As a highly-trained medical oncologist, she is experienced in diagnosing, assessing and treating patients with a variety of malignancies and benign hematologic disorders.
Dr. Lakhani grew up in Hinsdale and is excited to return to her hometown. “It is wonderful to be able to come back home to Hinsdale in a professional capacity where I can help meet the healthcare needs of our community,” she noted. “The Illinois Cancer Specialists Hinsdale facility is dedicated to delivering outstanding care and access to leading-edge clinical trials, right here at home. Because they are in The US Oncology Network, I’ll be joining nearly 1,000 physicians across the nation to improve quality and access to cancer care. It is a privilege to be part of an organization so committed to providing the best outcomes for the patients they serve.”
With 17 board certified physicians, Illinois Cancer Specialists offers convenient, compassionate care in five locations including Arlington Heights, Bolingbrook, Chicago, Hinsdale and Niles. For more information, visit www.illinoiscancerspecialists.com or to make an appointment call 630-654-1790.
About Illinois Cancer Specialists
Illinois Cancer Specialists (ICS) is dedicated to providing convenient, compassionate leading-edge cancer care to patients in Chicago and the surrounding areas. With more than 30 years in practice and over 400 years of combined experience, ICS is changing the forefront of patient care. Our dedicated and highly-skilled physicians and staff, who specialize in caring for patients with cancer and blood disorders, provide unparalleled access to the most innovative, advanced therapies and latest technologies throughout Chicago and the surrounding areas. With 17 board certified physicians, ICS offers convenient, compassionate care in five locations including Arlington Heights, Bolingbrook, Chicago, Hinsdale and Niles. For more information about Illinois Cancer Specialists visit www.illinoiscancerspecialists.com.
Illinois Cancer Specialists is united in healing with The US Oncology Network, one of the nation’s largest networks of integrated, community-based oncology practices dedicated to advancing high-quality, evidence-based cancer care. As an affiliate of The US Oncology Network, ICS is united with nearly 1,000 physicians nationwide. Illinois Cancer Specialists participates in clinical trials through US Oncology Research, which has played a role in 48 FDA-approved cancer therapies, nearly one-third of all cancer therapies approved by the FDA to date. For more information, visit www.usoncology.com.